Croda International (LON:CRDA) Insider Stephen Oxley Purchases 5 Shares of Stock

Croda International Plc (LON:CRDA) insider Stephen Oxley acquired 5 shares of the stock in a transaction on Monday, October 12th. The stock was bought at an average cost of GBX 3,388 per share, for a total transaction of £169.40.

Stephen Oxley also recently made the following trade(s):

• On Thursday, September 10th, Stephen Oxley bought 4 shares of Croda International stock. The shares were bought at an average cost of GBX 3,218 per share, with a total value of £128.72.
• On Monday, August 10th, Stephen Oxley bought 5 shares of Croda International stock. The shares were bought at an average cost of GBX 3,292 per share, with a total value of £164.60.
• On Monday, August 3rd, Stephen Oxley sold 1,339 shares of Croda International stock. The stock was sold at an average price of GBX 3,214, for a total transaction of £43,035.46.

Croda International Stock Performance

Shares of CRDA stock traded up GBX 100 during trading hours on Tuesday, hitting GBX 3,517. 463,121 shares of the company were exchanged, compared to its average volume of 4,424,601. The company has a current ratio of 2.57, a quick ratio of 2.25 and a debt-to-equity ratio of 36.06. The stock has a market capitalization of £4.90 billion, a price-to-earnings ratio of 61.81, a P/E/G ratio of 1.40 and a beta of 0.92. The firm has a fifty day simple moving average of GBX 3,295.78 and a 200 day simple moving average of GBX 3,075.73. Croda International Plc has a 52-week low of GBX 2,488 and a 52-week high of GBX 3,543.

Croda International (LON:CRDA) last posted its quarterly earnings data on Tuesday, July 28th. The company reported GBX 72.20 EPS for the quarter. Croda International had a return on equity of 3.65% and a net margin of 4.61%. Research analysts predict that Croda International Plc will post 181.83 earnings per share for the current fiscal year.

Analysts Set New Price Targets

CRDA has been the topic of several research reports. Citigroup boosted their target price on Croda International from GBX 3,050 to GBX 3,200 and gave the company a “neutral” rating in a research note on Wednesday, July 29th. Berenberg Bank reiterated a “buy” rating and set a GBX 3,600 price target on shares of Croda International in a research note on Wednesday, July 29th. Jefferies Financial Group reiterated a “buy” rating and set a GBX 4,000 price target on shares of Croda International in a research note on Friday, September 25th. Finally, Deutsche Bank Aktiengesellschaft reissued a “hold” rating and issued a GBX 3,300 price objective on shares of Croda International in a report on Wednesday, July 29th. Three analysts have rated the stock with a Buy rating and two have issued a Hold rating to the company’s stock. Based on data from MarketBeat, the company currently has a consensus rating of “Moderate Buy” and an average price target of GBX 3,490.

Croda International Company Profile

Founded in 1925 with the aim of turning bio-based raw materials into innovative ingredients, Croda International is a speciality chemicals company focused on consumer care and life sciences markets. The company is focused on creating, making and selling innovative ingredients that deliver real benefits to a diverse range of customers and employs more than 6,000 people around the world. Sustainability is a core part of the Groups strategy with a commitment to be Climate, Land and People positive by 2030.